Sign In
Buy ADAPY
Adaptimmune Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -96.51. In total, the insiders bought 75M and sold 84.28M ADAPY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-96.51 |
| ● Buy | 75M shares |
| ● Sell | 84.28M shares |
|
53% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 15, 2024 Buy |
Rawcliffe Adrian Chief Executive Officer |
1 696 272 Value: $2K |
||
|
Jan 12, 2024 Sell |
Norry Elliot Chief Medical Officer |
7 799 Value: $7K |
||
|
Jan 12, 2024 Sell |
Bertrand William C Jr Chief Operating Officer |
5 220 Value: $4K |
||
|
Jan 12, 2024 Sell |
Rawcliffe Adrian Chief Executive Officer |
17 257 Value: $14.7K |
||
|
Jan 12, 2024 Sell |
Lunger John Chief Patient Supply Officer |
5 220 Value: $4K |
||
|
Jan 11, 2024 Sell |
Norry Elliot Chief Medical Officer |
4 009 Value: $3K |
||
|
Jan 11, 2024 Sell |
Bertrand William C Jr Chief Operating Officer |
4 009 Value: $3K |
||
|
Jan 11, 2024 Sell |
Rawcliffe Adrian Chief Executive Officer |
11 945 Value: $10K |
||
|
Jan 11, 2024 Sell |
Lunger John Chief Patient Supply Officer |
4 009 Value: $3K |
||
|
Nov 01, 2023 Buy |
Hege Kristen Director |
1 000 000 Value: $90.0K |
||
|
Sep 01, 2023 Sell |
Rawcliffe Adrian Chief Executive Officer |
2 403 Value: $2K |
||
|
Aug 01, 2023 Sell |
Lunger John Chief Patient Supply Officer |
3 096 Value: $3K |
||
|
Jul 10, 2023 Sell |
Menzel Garry E Director |
47 702 Value: $43.4K |
||
|
Jul 05, 2023 Buy |
Hegde Priti Director |
226 464 Value: $400.8K |
||
|
Jul 05, 2023 Buy |
Hegde Priti Director |
152 376 Value: $16.8K |
||
|
Jul 05, 2023 Buy |
Hegde Priti Director |
109 746 Value: $62.6K |
||
|
Jul 05, 2023 Buy |
Allen Andrew R Director |
152 376 Value: $16.8K |
||
|
Jul 05, 2023 Buy |
Allen Andrew R Director |
109 746 Value: $62.6K |
||
|
Jul 05, 2023 Buy |
Allen Andrew R Director |
109 746 Value: $385.2K |
||
|
Jul 05, 2023 Buy |
Allen Andrew R Director |
73 212 Value: $65.2K |
||
|
Jul 05, 2023 Buy |
Allen Andrew R Director |
56 868 Value: $101.2K |
||
|
Jul 05, 2023 Buy |
Allen Andrew R Director |
45 348 Value: $80.7K |
||
|
Jul 05, 2023 Buy |
Menzel Garry E Director |
3 568 026 Value: $2.32M |
||
|
Jul 05, 2023 Buy |
Menzel Garry E Director |
2 715 816 Value: $1.55M |
||
|
Jul 05, 2023 Buy |
Menzel Garry E Director |
2 158 776 Value: $237.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
